Press Release: CILcare-CBSET receive Hearing Technology Innovator Awards for their cutting-edge preclinical auditory services in therapeutics category

LEXINGTON, MA, USA, October 21st, 2022 — CILcare, a leading R&D services company dedicated to ear disorders, announced today that the company, and its partner CBSET Inc., a not-for-profit translational research institute, have been recognized for their innovative preclinical auditory services in the third annual Hearing Technology Innovator Awards™. Through the annual awards program, Hearing […]

Press Release: Preclinical Study Provides Guidance for Optimizing Safety and Efficacy of Endovascular Hepatic Denervation Devices to Treat Diabetes

“Our study has documented, for the first time, the distributionof nerves and adjacent anatomies surrounding human hepatic arteries. This is the foundation for the development of catheter-based denervation technologies, providing invaluable guidance on the preferred treatment locations and depths in order to be effective,” said Dr. Rami Tzafriri, Director of Research & Innovation for CBSET […]

MD+DI: COVID-19 One Year Later: Can’t Keep a Medical Device Startup Down

How one medtech startup and its preclinical research partner overcame pandemic-related obstacles to continue its medical device research project. Prior to COVID-19, VentureMed was on a roll. The Minneapolis, MN-based company’s first-generation Flex Vessel Prep System had demonstrated promising clinical performance following FDA clearance and the company was preparing to introduce an improved second-generation device. […]

Press Release: CBSET-CILcare to report experimental methodologies for performing cochlear implant studies in anatomically relevant large species at the ‘ARO 2021 Virtual Midwinter Meeting’

“Auditory research studies are typically performed using rodent models. Yet, owing to their size, implant studies often require a larger species with middle and inner ear anatomy more relevant to humans,” said Misty Williams-Fritze, DVM, MS, DACLAM, CBSET, co-lead researcher. Lexington, MA — February 19, 2021 — CBSET Inc., a not-for-profit translational research institute, announced […]

Cardiovascular News: FLEX Vessel Prep™ System Data Presented During Leipzig Interventional Course (LINC) 2021

Trio of studies demonstrate that FLEX Vessel Prep System safely and effectively modifies obstructive plaque to facilitate delivery of definitive therapies MINNEAPOLIS, Jan. 27, 2021 — VentureMed Group, Inc. (VentureMed), a privately-held medical device innovator, announced today that data from three studies evaluating the use of its FLEX Vessel Prep (VP) System were presented during […]

Press Release: CBSET partner CILcare opens new subsidiary in Denmark

Montpellier, France — November 9, 2020  — CBSET partner CILcare, a world leading CRO entirely dedicated to ear disorders, announced today the opening of a new subsidiary in Copenhagen, Denmark. Already established in the US, the French company is joining the Medicon Valley Alliance, a leading international life-sciences cluster in Northern Europe. This second subsidiary […]

Press Release: Preclinical studies reveal balloon-based drug delivery to be critically dependent on coating micro-morphology, suggesting a paradigm for accelerated treatment optimization

“These preclinical studies transform our understanding of how drug coated balloons deliver drug to the artery and why there is no class effect, while also providing tools for understanding the role of tissue stiffening with disease. The combination of mechanistic insight with predictive modeling can help accelerate development of new technologies such as those including […]